AZN Dividend History Chart
AstraZeneca PLC ADR (AZN) Dividend Payments
| Ex-Dividend Date | Record Date | Payment Date | Dividend | Frequency |
|---|---|---|---|---|
| Aug 7, 2026 | Aug 7, 2026 | Sep 8, 2026 | $1.06 | Semi-Annual |
| Feb 20, 2026 | Feb 20, 2026 | Mar 23, 2026 | $2.17 | Semi-Annual |
| Aug 8, 2025 | Aug 8, 2025 | Sep 8, 2025 | $1.03 | Semi-Annual |
| Feb 21, 2025 | Feb 21, 2025 | Mar 24, 2025 | $2.12806 | Semi-Annual |
| Aug 9, 2024 | Aug 9, 2024 | Sep 9, 2024 | $1 | Semi-Annual |
| Feb 22, 2024 | Feb 23, 2024 | Mar 25, 2024 | $1.97 | Semi-Annual |
| Aug 10, 2023 | Aug 11, 2023 | Sep 11, 2023 | $0.93 | Semi-Annual |
| Feb 23, 2023 | Feb 24, 2023 | Mar 27, 2023 | $1.97 | Semi-Annual |
| Aug 11, 2022 | Aug 12, 2022 | Sep 12, 2022 | $0.93177 | Semi-Annual |
| Feb 24, 2022 | Feb 25, 2022 | Mar 28, 2022 | $1.97 | Semi-Annual |
| Aug 12, 2021 | Aug 13, 2021 | Sep 13, 2021 | $0.89648 | Semi-Annual |
| Feb 25, 2021 | Feb 26, 2021 | Mar 29, 2021 | $1.94181 | Semi-Annual |
| Aug 13, 2020 | Aug 14, 2020 | Sep 14, 2020 | $0.91138 | Semi-Annual |
| Feb 27, 2020 | Feb 28, 2020 | Mar 30, 2020 | $1.88468 | Semi-Annual |
| Aug 8, 2019 | Aug 9, 2019 | Sep 9, 2019 | $0.8724 | Semi-Annual |
| Feb 28, 2019 | Mar 1, 2019 | Mar 27, 2019 | $1.9 | Semi-Annual |
| Aug 9, 2018 | Aug 10, 2018 | Sep 10, 2018 | $0.9 | Semi-Annual |
| Feb 15, 2018 | Feb 16, 2018 | Mar 19, 2018 | $1.9 | Semi-Annual |
| Aug 9, 2017 | Aug 11, 2017 | Sep 11, 2017 | $0.9 | Semi-Annual |
| Feb 15, 2017 | Feb 17, 2017 | Mar 20, 2017 | $1.9 | Semi-Annual |
| Aug 10, 2016 | Aug 12, 2016 | Sep 12, 2016 | $0.9 | Semi-Annual |
| Feb 17, 2016 | Feb 19, 2016 | Mar 21, 2016 | $1.9 | Semi-Annual |
| Aug 12, 2015 | Aug 14, 2015 | Sep 14, 2015 | $0.9 | Semi-Annual |
| Feb 18, 2015 | Feb 20, 2015 | Mar 23, 2015 | $1.9 | Semi-Annual |
| Aug 13, 2014 | Aug 15, 2014 | Sep 15, 2014 | $0.9 | Semi-Annual |
| Feb 19, 2014 | Feb 21, 2014 | Mar 24, 2014 | $1.9 | Special |
| Aug 14, 2013 | Aug 16, 2013 | Sep 16, 2013 | $0.9 | Semi-Annual |
| Feb 13, 2013 | Feb 15, 2013 | Mar 18, 2013 | $1.9 | Special |
| Aug 8, 2012 | Aug 10, 2012 | Sep 10, 2012 | $0.9 | Semi-Annual |
| Feb 15, 2012 | Feb 17, 2012 | Mar 19, 2012 | $1.95 | Semi-Annual |
| Aug 4, 2011 | Aug 8, 2011 | Sep 12, 2011 | $0.85 | Semi-Annual |
| Feb 2, 2011 | Feb 4, 2011 | Mar 14, 2011 | $1.85 | Semi-Annual |
| Aug 4, 2010 | Aug 6, 2010 | Sep 13, 2010 | $0.7 | Semi-Annual |
| Feb 3, 2010 | Feb 5, 2010 | Mar 15, 2010 | $1.71 | Semi-Annual |
| Aug 5, 2009 | Aug 7, 2009 | Sep 14, 2009 | $0.59 | Semi-Annual |
| Feb 4, 2009 | Feb 6, 2009 | Mar 16, 2009 | $1.5 | Semi-Annual |
| Aug 6, 2008 | Aug 8, 2008 | Sep 15, 2008 | $0.55 | Semi-Annual |
| Feb 7, 2008 | Feb 11, 2008 | Mar 17, 2008 | $1.35 | Semi-Annual |
| Aug 8, 2007 | Aug 10, 2007 | Sep 17, 2007 | $0.52 | Semi-Annual |
| Feb 7, 2007 | Feb 9, 2007 | Mar 19, 2007 | $1.23 | Semi-Annual |
| Aug 9, 2006 | Aug 11, 2006 | Sep 18, 2006 | $0.49 | Semi-Annual |
| Feb 8, 2006 | Feb 10, 2006 | Mar 20, 2006 | $0.92 | Semi-Annual |
AZN Dividend Statistics
Summary
AstraZeneca PLC ADR (AZN) currently offers a dividend yield of 1.88% and has maintained a dividend growth streak of 2 years. While the company pays regular dividends, its long-term dividend growth history is still limited.
AZN vs Top Dividend Stocks
| Company | Dividend Yield | Annual Dividend | Ex-Date |
|---|---|---|---|
| UnitedHealth Group | 2.17% | $9.06 | Sep 13, 2026 |
| Johnson & Johnson | 2% | $5.28 | Aug 24, 2026 |
| Merck & Company, Inc. | 2.34% | $3.4 | Sep 14, 2026 |
| Amgen Inc. | 2.26% | $9.94 | Aug 20, 2026 |
| Regeneron Pharmaceuticals, Inc. | 0.46% | $3.7 | Aug 17, 2026 |
| Eli Lilly and Company | 0.52% | $6.69 | Aug 13, 2026 |
| Pfizer Inc. | 5.73% | $1.72 | Jul 23, 2026 |
| Novo Nordisk A/S | 4.6% | $1.796 | Aug 16, 2026 |
| AbbVie | 2.42% | $6.92 | Oct 14, 2026 |
| Stryker Corporation | 1.15% | $3.52 | Sep 29, 2026 |
Methodology
We calculate dividend metrics using dividend payment records, historical stock prices, and company financial data obtained from trusted market data providers, including Twelve Data, Financial Modeling Prep (FMP), and Polygon.io. Historical dividend data is available from 2004 onward, subject to company listing history and data availability
Want to invest in stocks?
You can get started with the brokers below.
These platforms allow you to buy and hold shares directly.
👉 Compare brokers and get started today.
AstraZeneca PLC ADR (AZN) Dividend FAQs
-
Does AstraZeneca PLC ADR (AZN) pay dividends?
Yes, AstraZeneca PLC ADR (AZN) currently pays dividends. The annual dividend (TTM) is $3.23 per share, with a current dividend yield of 1.88%.
-
What is AstraZeneca PLC ADR (AZN)'s current dividend yield?
AstraZeneca PLC ADR (AZN)'s current dividend yield is 1.88%, based on the latest annual dividend (TTM) and current share price.
-
When is AstraZeneca PLC ADR (AZN)'s ex-dividend date?
No upcoming ex-dividend date has been announced.
-
What is AstraZeneca PLC ADR (AZN)'s dividend payment frequency?
AstraZeneca PLC ADR (AZN) pays dividends semi-annual.
-
Has AstraZeneca PLC ADR (AZN) increased its dividend over time?
Yes. AstraZeneca PLC ADR (AZN) has increased its annual dividend for 2 consecutive years.
Latest AZN News
Amgen lung cancer combo shows survival gain in late-stage trial
Ultomiris and ZEGFROVY approvals lift AstraZeneca stock as buyer support prevails
AstraZeneca stock rises 2.4% as nine-month and third-quarter 2026 results
AstraZeneca stock trades flat as buyers maintain support despite mixed momentum signals
AstraZeneca secures Phase 3 Tezspire success: AZN gains momentum
Disclaimer
All information on the pages containing forecasts, video forecasts, and other analytical materials is published ‘as is’ and for informational purposes only. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.
No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.
The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.
Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.
You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.
Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.
Our company shall not be liable for the products and services advertised on our website.
General websites Disclaimer:
Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Risk disclosure:
Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.
That is why you should only invest money you are willing and able to lose, given the high level of risk involved. Tradersunion.com does not offer financial services, including investment or financial advisory services. Traders Union is not a broker and does not receive compensation for trading in the Forex or CFD markets. Our website only provides informational content about brokers and financial markets and helps users choose the most suitable brokerage company based on comprehensive data and objective analysis..